Literature DB >> 10946219

Immunological responses to oxidized LDL.

S Hörkkö1, C J Binder, P X Shaw, M K Chang, G Silverman, W Palinski, J L Witztum.   

Abstract

Considerable evidence now points to an important role for the immune system in experimental models of atherosclerosis. We have reviewed the growing body of evidence that oxidation of LDL generates a wide variety of neoself determinants that lead to cellular and humoral immune responses. In particular, we have demonstrated that at least some of the oxidation-specific epitopes generated on the oxidized LDL particle, such as oxidized phospholipid epitopes, are also generated on apoptotic cells and are also present on the surface of some bacteria. Many of these same epitopes serve as important ligands mediating the binding and clearance of oxidatively damaged lipoprotein particles and apoptotic cells, and the innate immune response to these epitopes can be seen as a concerted response to effect their removal. In addition, other epitopes of OxLDL also undoubtedly play a role in the immune activation that characterizes the progressive atherosclerotic plaque. It will be of great importance to define the importance of the role of these responses and to understand which are beneficial and which deleterious. Such information could lead one day to novel therapeutic approaches to inhibit atherogenesis that take advantage of the ability to manipulate the immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946219     DOI: 10.1016/s0891-5849(00)00333-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  29 in total

1.  Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?

Authors:  Joseph L Witztum
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 3.  Intravenous immunoglobulin and atherosclerosis.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Katsumi Inoue; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

4.  Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.

Authors:  Corrilynn O Hileman; Bruce Kinley; Valeska Scharen-Guivel; Kathy Melbourne; Javier Szwarcberg; Janet Robinson; Michael M Lederman; Grace A Mccomsey
Journal:  J Infect Dis       Date:  2015-01-12       Impact factor: 5.226

5.  Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.

Authors:  Aulikki Kononoff; Pia Elfving; Pirkko Pussinen; Sohvi Hörkkö; Hannu Kautiainen; Leena Arstila; Leena Laasonen; Elina Savolainen; Helena Niinisalo; Jarno Rutanen; Olga Marjoniemi; Mari Hämäläinen; Katriina Vuolteenaho; Eeva Moilanen; Oili Kaipiainen-Seppänen
Journal:  Ann Med       Date:  2020-02-10       Impact factor: 4.709

6.  Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed Apoe-/- Mice.

Authors:  Olga A Cherepanova; Prasad Srikakulapu; Elizabeth S Greene; Malay Chaklader; Ryan M Haskins; Mary E McCanna; Smarajit Bandyopadhyay; Bhupal Ban; Norbert Leitinger; Coleen A McNamara; Gary K Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-24       Impact factor: 8.311

7.  Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.

Authors:  H A Schenkein; C R Berry; D Purkall; J A Burmeister; C N Brooks; J G Tew
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein.

Authors:  Nurcan Cengiz; Esra Baskin; Nurzen Sezgin; Pinar Agras; Mehmet Haberal
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

9.  Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

Authors:  Roya Kelishadi
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.